Home/Pipeline/LNTH-2401

LNTH-2401

Metastatic Prostate Cancer

Phase 2Active

Key Facts

Indication
Metastatic Prostate Cancer
Phase
Phase 2
Status
Active
Company

About Lantheus Medical Imaging

Lantheus Medical Imaging is a leading public radiopharmaceutical company with a mission to 'Find, Fight, and Follow' disease through targeted diagnostic and therapeutic innovations. The company has achieved significant commercial success with products like PYLARIFY for prostate cancer imaging and is aggressively expanding its pipeline through strategic acquisitions and internal R&D into high-growth areas like radiotherapeutics and neurology diagnostics. Its strategy hinges on vertical integration, managing complex radiopharmaceutical logistics, and capitalizing on the growing precision medicine paradigm in nuclear medicine.

View full company profile

Other Metastatic Prostate Cancer Drugs

DrugCompanyPhase
Decipher Prostate MetastaticVeracyteCommercial